Biopharma Business

Tag "Diamond BioPharm"

Diamond BioPharm’s Response to the United Kingdom’s Withdrawal from the European Union

On May 2, 2017, the EMA and European Commission published a notice alerting Marketing Authorization Holders of centrally authorized medicines of their obligations in relation to Brexit. Although the final

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here